180 Life Sciences Corp. Announces $425 Million Private Placement to Establish Ethereum Treasury and Rebrand as ETHZilla
180 Life Sciences Corp. has announced a $425 million private investment in public equity $(PIPE)$ transaction to enhance its treasury reserve with Ether, the native digital asset of Ethereum. The transaction, expected to close around August 1, 2025, involves the sale of common stock and possibly pre-funded warrants, with investors being granted registration rights. Following the closing, the company plans to rebrand as ETHZilla Corporation. Additionally, 180 Life Sciences has approval to sell up to $150 million in debt securities, which it plans to offer after the PIPE transaction. Clear Street LLC served as the financial advisor and exclusive placement agent for the offering.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 180 Life Sciences Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY39651) on July 29, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。